Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. Price to FCF Ratio 2011–2026
Price to free cash flow (P/FCF) ratio for Pacira BioSciences Inc. (PCRX): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 6.77.
From: 06/30/2011To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Pacira BioSciences Inc. Price to FCF Ratio — FAQ
Pacira BioSciences Inc. (PCRX) price to fcf ratio over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCRX's price to fcf ratio history?
The chart and table above show Pacira BioSciences Inc.'s price to fcf ratio by year and by quarter, including the growth rate.